Basic Information
TOLTERODINE MEVON SR CAPSULE 4 MG
CAPSULE, EXTENDED RELEASE
Regulatory Information
SIN16432P
February 28, 2022
Prescription Only
Therapeutic
ORAL
August 10, 2023
June 3, 2025
XG04BD07
Company Information
Active Ingredients
Tolterodine Tartrate
Strength: 4 mg
Detailed Information
Contraindications
**4.3 Contraindications** Tolterodine is contraindicated in patients with: - Hypersensitivity to the active substance or to any of the excipients listed in section 6.1 – _please refer to the Product Insert/Patient Information Leaflet published on HSA for the full drug information_ - Urinary retention - Uncontrolled narrow angle glaucoma
Indication Information
**4.1 Therapeutic indications** Tolterodine is indicated for the treatment of overactive bladder with symptoms of urinary urgency, frequency, and/or urge incontinence.